Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘19 |
|
|---|---|---|---|---|---|
| $26.6M | $31.5M | $4.93M | 31.6% |
|
|
| $26.2M | $64.5M | $38.3M | 522% |
|
|
| $26.1M | $49M | $22.9M | 3.75% |
|
|
254
ProShares UltraPro Short S&P 500
SPXU
$475M
| $25.7M | $68.9M | $43.2M | 98.1% |
|
| $25.7M | $38.6M | $12.9M | 58.2% |
|
|
| $25.5M | $36.2M | $10.8M | 53.7% |
|
|
| $25.4M | $219M | $193M | 39% |
|
|
| $25.2M | $56.9M | $31.7M | 275% |
|
|
| $25M | $224M | $199M | 61.5% |
|
|
| $24.9M | $56.8M | $31.9M | 98.4% |
|
|
261
Iovance Biotherapeutics
IOVA
$1.5B
| $24.9M | $28.1M | $3.26M | 79.2% |
|
| $24.8M | $167M | $142M | 0.58% |
|
|
| $24.6M | $197M | $172M | 118% |
|
|
| $24.6M | $65.1M | $40.5M | 109% |
|
|
| $24.5M | $36.9M | $12.4M | 70.3% |
|
|
| $24.4M | $41.5M | $17.1M | 81.6% |
|
|
| $24M | $98.8M | $74.8M | 38.4% |
|
|
| $24M | $27.3M | $3.28M | 74.5% |
|
|
| $23.8M | $89.5M | $65.7M | 44.8% |
|
|
| $23.6M | $77.3M | $53.8M | 16.6% |
|
|
| $23.5M | $57.3M | $33.8M | 15.4% |
|
|
| $23.4M | $60.9M | $37.5M | 93.5% |
|
|
| $23.4M | $51.7M | $28.3M | 80.2% |
|
|
| $22.8M | $29.5M | $6.71M | 315% |
|
|
| $22.8M | $42.3M | $19.5M | 190% |
|